What is Wasatch Infusion?
Wasatch Infusion operates as a specialized provider of private IV therapy, distinguishing itself through a model that prioritizes patient comfort, safety, and cost-efficiency. By offering both medical-grade IV treatments and wellness-focused infusions in private, personalized suites, the company has effectively disrupted traditional clinical delivery models. Its strategic focus on high-touch, low-cost service delivery positioned it as an attractive acquisition target, ultimately leading to its integration into Option Care Health. This merger allows the entity to leverage broader resources while maintaining its commitment to specialized infusion services across the Utah market.
How much funding has Wasatch Infusion raised?
Wasatch Infusion has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Wasatch Infusion
PPP
Public-Private Partnership
What's next for Wasatch Infusion?
Following its integration into the Option Care Health ecosystem, Wasatch Infusion is poised to scale its service delivery model across a wider geographic footprint. The strategic roadmap likely involves optimizing operational efficiencies and expanding the breadth of infusion therapies available to patients. As the healthcare sector continues to shift toward outpatient and home-based care, the infrastructure established by Wasatch Infusion provides a robust foundation for sustained growth. Future initiatives will likely focus on integrating advanced clinical protocols and enhancing patient access, ensuring that the brand remains a leader in the specialized infusion therapy market while benefiting from the economies of scale provided by its parent organization.
See full Wasatch Infusion company page
